IL117531A - Transparent rapid release compositions of non-steroidal analgesics - Google Patents

Transparent rapid release compositions of non-steroidal analgesics

Info

Publication number
IL117531A
IL117531A IL11753196A IL11753196A IL117531A IL 117531 A IL117531 A IL 117531A IL 11753196 A IL11753196 A IL 11753196A IL 11753196 A IL11753196 A IL 11753196A IL 117531 A IL117531 A IL 117531A
Authority
IL
Israel
Prior art keywords
pct
rapid release
release compositions
steroidal analgesics
date sep
Prior art date
Application number
IL11753196A
Other languages
English (en)
Other versions
IL117531A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL117531A0 publication Critical patent/IL117531A0/xx
Publication of IL117531A publication Critical patent/IL117531A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Finger-Pressure Massage (AREA)
IL11753196A 1995-03-21 1996-03-18 Transparent rapid release compositions of non-steroidal analgesics IL117531A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19509805A DE19509805A1 (de) 1995-03-21 1995-03-21 Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica

Publications (2)

Publication Number Publication Date
IL117531A0 IL117531A0 (en) 1996-07-23
IL117531A true IL117531A (en) 2000-01-31

Family

ID=7757016

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11753196A IL117531A (en) 1995-03-21 1996-03-18 Transparent rapid release compositions of non-steroidal analgesics

Country Status (21)

Country Link
US (1) US6063821A (cs)
EP (1) EP0817612B1 (cs)
JP (1) JPH11502209A (cs)
KR (1) KR19980703160A (cs)
AT (1) ATE196078T1 (cs)
AU (1) AU5105396A (cs)
BR (1) BR9607867A (cs)
CA (1) CA2213719C (cs)
CZ (1) CZ286011B6 (cs)
DE (2) DE19509805A1 (cs)
DK (1) DK0817612T3 (cs)
EA (1) EA000434B1 (cs)
ES (1) ES2151150T3 (cs)
GR (1) GR3034441T3 (cs)
HU (1) HU221614B (cs)
IL (1) IL117531A (cs)
NO (1) NO318236B1 (cs)
PT (1) PT817612E (cs)
TW (1) TW416850B (cs)
WO (1) WO1996029053A1 (cs)
ZA (1) ZA962241B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602206A1 (de) 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
CN1237902A (zh) * 1996-11-15 1999-12-08 默克专利股份公司 制造成形和非成形多元醇材料的方法
JP4947833B2 (ja) * 1997-07-25 2012-06-06 アルペックス・ファルマ・ソシエテ・アノニム 速崩壊性口内溶解錠の製造に適した顆粒の製造方法
WO2001034119A2 (en) * 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
ES2170645B1 (es) * 2000-03-23 2003-10-01 Alcala Farma S L Lab Forma farmaceutica solida de administracion oral de una sal de metamizol soluble en agua, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
JP2006500349A (ja) 2002-08-12 2006-01-05 ファイザー・プロダクツ・インク 半順序薬剤およびポリマーの医薬組成物
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
WO2007012022A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Unit dose form with ibuprofen-famotidine admixture
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
US20100074947A1 (en) * 2008-06-13 2010-03-25 Adrian Brown Pharmaceutical Formulations
JP5499703B2 (ja) * 2009-12-28 2014-05-21 ライオン株式会社 イブプロフェン含有製剤
EP2553003A1 (en) * 2010-03-26 2013-02-06 Dow Global Technologies LLC Melt-extruded film
US20110236666A1 (en) * 2010-03-26 2011-09-29 Hall Mark J Melt-extruded film

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
EP0607467B1 (de) * 1992-12-01 1999-06-02 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel
GB9302259D0 (en) * 1993-02-05 1993-03-24 Cerestar Holding Bv Starch based material
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren

Also Published As

Publication number Publication date
HU221614B (hu) 2002-11-28
EP0817612A1 (de) 1998-01-14
US6063821A (en) 2000-05-16
EA199700247A1 (ru) 1998-02-26
CZ280297A3 (cs) 1998-03-18
NO974338L (no) 1997-09-19
DK0817612T3 (da) 2000-11-20
DE59605848D1 (de) 2000-10-12
CA2213719A1 (en) 1996-09-26
MX9706652A (es) 1997-11-29
WO1996029053A1 (de) 1996-09-26
BR9607867A (pt) 1998-06-30
HUP9801152A3 (en) 2000-06-28
TW416850B (en) 2001-01-01
AU5105396A (en) 1996-10-08
ATE196078T1 (de) 2000-09-15
CA2213719C (en) 2005-01-11
HUP9801152A2 (hu) 1998-08-28
EP0817612B1 (de) 2000-09-06
IL117531A0 (en) 1996-07-23
NO318236B1 (no) 2005-02-21
GR3034441T3 (en) 2000-12-29
NO974338D0 (no) 1997-09-19
ZA962241B (en) 1997-09-22
EA000434B1 (ru) 1999-08-26
ES2151150T3 (es) 2000-12-16
DE19509805A1 (de) 1996-09-26
JPH11502209A (ja) 1999-02-23
KR19980703160A (ko) 1998-10-15
PT817612E (pt) 2001-03-30
CZ286011B6 (cs) 1999-12-15

Similar Documents

Publication Publication Date Title
IL117531A (en) Transparent rapid release compositions of non-steroidal analgesics
NO974337D0 (no) Lagringsstabile legemiddelformer
ES2177758T3 (es) Composicion antimicrobiana compuesta de vidrios de liberacion controlada.
AU2916792A (en) Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
IL117532A0 (en) Production of compositions in the form of a solid solution of an active substance in a polymer matrix
EP0753296A3 (en) Oral formulations containing S (+) - ibuprofen
ATE168886T1 (de) Abgabevorrichtung mit eingekapselten hilfsmitteln
DE69621785D1 (de) Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
AU2736495A (en) Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites
NO963634D0 (no) Antihostepreparat inneholdende et antihostemiddel og benzydamin
AU6303996A (en) Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
DK0749304T4 (da) Retardtablet med et indhold af diclofenac-Na
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
PL335652A1 (en) Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid
YU71595A (sh) Optičko pomoćno sredstvo

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed